Seeking Alpha

Carl Icahn's bid to have a hand in Clorox (CLX) looks far from over after he nominates his own...

Carl Icahn's bid to have a hand in Clorox (CLX) looks far from over after he nominates his own slate of candidates to sit on the firm's board. The activist investor is coming off a boardroom defeat to Forest Laboratories (FRX) earlier this week.
Comments (1)
  • 2PP
    , contributor
    Comments (349) | Send Message
     
    C'mon Icahn make a better offer. Next time CLX spikes, I'll let it go.
    19 Aug 2011, 08:50 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|